RA

Rajenthiran Aswini

Active Director Managing Director DIN 10100715
DIN 10100715 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajenthiran Aswini

Data last updated:

Rajenthiran Aswini is a Managing Director at Allora Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10100715
Primary Designation Managing Director
Industry Pharma
First Appointment 05 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director05 Apr 20232023Active

Board colleagues of Rajenthiran Aswini

NameDINCompanyDesignation
Naveenan10373539Allora Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Allora Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajenthiran Aswini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajenthiran Aswini

Rajenthiran Aswini currently holds 1 directorship: Allora Pharmaceuticals Private Limited (Managing Director, since 05 Apr 2023).

Rajenthiran Aswini was first appointed on 05 Apr 2023 as Managing Director at Allora Pharmaceuticals Private Limited.

The current boards of Rajenthiran Aswini's companies include Naveenan (Allora Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available